Announce Date | 04/29/2025 |
EPS Normalized Actual | $-0.00161 (Miss by $-0.10161) |
EPS GAAP Actual | $-0.00161 (Miss by $-0.10161) |
Revenue Actual | $0.359343B |
Revenue Surprise | Beat by $359.343M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.08 | 7.18 | 1.03313 | 1.11058 | 1 |
Dec 2029 | 1.08 | 7.18 | 1.04501 | 1.107 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.0016 | -0.0016 | 0.359343B | 2.52% | 359.34M |
FQ4 2024 (Dec 2024) | 0.16 | 0.16 | 1.47259B | 76.38% | 1472.59M |
FQ3 2024 (Sep 2024) | 0.0303 | 0.0303 | 0.393296B | 3.38% | 393.3M |
FQ2 2024 (Jun 2024) | 0.0639 | 0.0639 | 0.379432B | 100% | 379.43M |
FQ1 2024 (Mar 2024) | -0.0076 | -0.0076 | 0.350305B | 100% | 350.31M |
FQ4 2023 (Dec 2023) | -0.0516 | -0.0516 | 0.347808B | -0.82% | 347.81M |
FQ3 2023 (Jul 2023) | 0.0234 | 0.0234 | 0.380019B | 0.39% | 380.02M |
FQ4 2022 (Dec 2022) | -0.071 | -0.071 | 0.350663B | 100% | 350.66M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.2 | -- | 0.19576 | 0.20628 | 1 |
FQ3 2027 (Sep 2027) | 0.26 | -- | 0.25351 | 0.26857 | 1 |
FQ2 2027 (Jun 2027) | 0.23 | -- | 0.22426 | 0.23759 | 1 |
FQ1 2027 (Mar 2027) | 0.15 | -- | 0.14626 | 0.15495 | 1 |
FQ4 2026 (Dec 2026) | 0.15 | -- | 0.15 | 0.15 | 2 |
FQ3 2026 (Sep 2026) | 0.205 | -- | 0.19989 | 0.21176 | 1 |
FQ2 2026 (Jun 2026) | 0.19 | -- | 0.18216 | 0.19808 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.41B | -- | 0.4B | 0.42B | 3 |
FQ3 2027 (Sep 2027) | 0.47B | -- | 0.46B | 0.48B | 2 |
FQ2 2027 (Jun 2027) | 0.44B | -- | 0.43B | 0.45B | 2 |
FQ1 2027 (Mar 2027) | 0.39B | -- | 0.39B | 0.4B | 2 |
FQ4 2026 (Dec 2026) | 0.38B | -- | 0.38B | 0.38B | 3 |
FQ3 2026 (Sep 2026) | 0.44B | -- | 0.43B | 0.45B | 2 |
FQ2 2026 (Jun 2026) | 0.4B | -- | 0.39B | 0.42B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.0016 | -0.0016 | 100% | |
FQ4 2024 (Dec 2024) | 0.16 | 0.16 | 100% | |
FQ3 2024 (Sep 2024) | 0.0303 | 0.0303 | 100% | |
FQ2 2024 (Jun 2024) | 0.0639 | 0.0639 | 100% | |
FQ1 2024 (Mar 2024) | -0.0076 | -0.0076 | 100% | |
FQ4 2023 (Dec 2023) | -0.0516 | -0.0516 | 100% | |
FQ3 2023 (Jul 2023) | 0.0234 | 0.0234 | 100% | |
FQ4 2022 (Dec 2022) | -0.071 | -0.071 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.36B | $359.34M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.47B | $1472.59M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.39B | $393.3M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.38B | $379.43M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.35B | $350.31M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.35B | $347.81M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.38B | $380.02M | 100% |
FQ4 2022 (Dec 2022) | $0B | $0.35B | $350.66M | 100% |